Medicus Pharma Ltd., an Ontario-based company, has announced the entry into a significant securities purchase agreement with YA II PN, Ltd. (Yorkville). Under this agreement, Medicus Pharma will issue debentures totaling up to $5 million, with Yorkville having already purchased debentures worth $5 million in aggregate principal. The company has received net proceeds of $4.5 million from these transactions. The debentures, which mature on February 2, 2026, carry an annual interest rate of 8%, potentially increasing to 18% in case of specific defaults. The debentures are backed by a global guaranty agreement involving the company's subsidiaries.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.